The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 01, 2019

Filed:

Dec. 27, 2012
Applicant:

Lion Corporation, Tokyo, JP;

Inventors:

Chiyoko Uchiyama, Tokyo, JP;

Kei Kurita, Tokyo, JP;

Eriko Fukushima, Tokyo, JP;

Riichi Maki, Tokyo, JP;

Assignee:

LION CORPORATION, Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/575 (2006.01); C07K 14/705 (2006.01); C07K 16/26 (2006.01); C07K 16/28 (2006.01); C12M 1/34 (2006.01); G01N 27/62 (2006.01); G01N 37/00 (2006.01); G01N 33/68 (2006.01); C07K 14/72 (2006.01); C07K 14/47 (2006.01); G01N 33/543 (2006.01); C07K 14/435 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); C07K 14/435 (2013.01); C07K 14/47 (2013.01); C07K 14/723 (2013.01); G01N 33/54366 (2013.01); G01N 2333/435 (2013.01); G01N 2800/04 (2013.01); G01N 2800/50 (2013.01);
Abstract

It is an object of the present invention to provide a marker substance capable of accurately determining a risk of developing metabolic syndrome in vivo. That is, the present invention provides the followings: a marker peptide for determining the risk of developing the metabolic syndrome; an antibody or an aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome; a microarray in which the antibody or the aptamer bound to the marker peptide for determining the risk of developing the metabolic syndrome has been immobilized on a carrier; a method for determining the risk of developing the metabolic syndrome, comprising measuring an amount or the presence or absence of the marker peptide for determining the risk of developing the metabolic syndrome in a biological sample collected from a subject; and a kit for determining the risk of developing the metabolic syndrome, comprising the antibody or the aptamer or comprising the microarray.


Find Patent Forward Citations

Loading…